{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:58:44Z","timestamp":1794254324600,"version":"4.9.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T00:00:00Z","timestamp":1303344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00228-011-1046-z","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T05:46:32Z","timestamp":1303278392000},"page":"993-1006","source":"Crossref","is-referenced-by-count":96,"title":["Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma"],"prefix":"10.1007","volume":"67","author":[{"given":"Barbara","family":"Faganel Kotnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iztok","family":"Grabnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bohanec Grabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Dol\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janez","family":"Jazbec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,21]]},"reference":[{"issue":"10","key":"1046_CR1","first-page":"3294","volume":"94","author":"A Reiter","year":"1999","unstructured":"Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, Mann G, Chott A, Ebell W, Klingebiel T, Graf N, Kremens B, Muller-Weihrich S, Pluss HJ, Zintl F, Henze G, Riehm H (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 94(10):3294\u20133306","journal-title":"Blood"},{"issue":"11","key":"1046_CR2","first-page":"3310","volume":"95","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 95(11):3310\u20133322","journal-title":"Blood"},{"issue":"8","key":"1046_CR3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","volume":"338","author":"WE Evans","year":"1998","unstructured":"Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH (1998) Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 338(8):499\u2013505","journal-title":"N Engl J Med"},{"issue":"17","key":"1046_CR4","first-page":"3790","volume":"55","author":"JA Moscow","year":"1995","unstructured":"Moscow JA, Gong M, He R, Sgagias MK, Dixon KH, Anzick SL, Meltzer PS, Cowan KH (1995) Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 55(17):3790\u20133794","journal-title":"Cancer Res"},{"issue":"14","key":"1046_CR5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","volume":"335","author":"R Gorlick","year":"1996","unstructured":"Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR (1996) Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 335(14):1041\u20131048","journal-title":"N Engl J Med"},{"issue":"5","key":"1046_CR6","first-page":"546","volume":"24","author":"R Takatori","year":"2006","unstructured":"Takatori R, Takahashi KA, Tokunaga D, Hojo T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T (2006) ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Clin Exp Rheumatol 24(5):546\u2013554","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"1046_CR7","first-page":"3416","volume":"7","author":"JR Whetstine","year":"2001","unstructured":"Whetstine JR, Gifford AJ, Witt T, Liu XY, Flatley RM, Norris M, Haber M, Taub JW, Ravindranath Y, Matherly LH (2001) Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G\/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res 7(11):3416\u20133422","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1046_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1247\/csf.20.191","volume":"20","author":"N Horie","year":"1995","unstructured":"Horie N, Aiba H, Oguro K, Hojo H, Takeishi K (1995) Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5\u2032-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 20(3):191\u2013197","journal-title":"Cell Struct Funct"},{"issue":"1","key":"1046_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111\u2013113","journal-title":"Nat Genet"},{"issue":"3","key":"1046_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","volume":"64","author":"I Weisberg","year":"1998","unstructured":"Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64(3):169\u2013172","journal-title":"Mol Genet Metab"},{"issue":"12","key":"1046_CR11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/hmg\/5.12.1867","volume":"5","author":"D Leclerc","year":"1996","unstructured":"Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA (1996) Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate\/cobalamin disorders. Hum Mol Genet 5(12):1867\u20131874","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1046_CR12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0021-9150(00)00739-5","volume":"157","author":"DJ Gaughan","year":"2001","unstructured":"Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS (2001) The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157(2):451\u2013456","journal-title":"Atherosclerosis"},{"issue":"1","key":"1046_CR13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","volume":"75","author":"C Marzolini","year":"2004","unstructured":"Marzolini C, Paus E, Buclin T, Kim RB (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75(1):13\u201333","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1046_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc1800","volume":"6","author":"MH Cheok","year":"2006","unstructured":"Cheok MH, Evans WE (2006) Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat Rev Cancer 6(2):117\u2013129","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1046_CR15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2165\/00003088-200645120-00007","volume":"45","author":"D Aumente","year":"2006","unstructured":"Aumente D, Buelga DS, Lukas JC, Gomez P, Torres A, Garcia MJ (2006) Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Clin Pharmacokinet 45(12):1227\u20131238","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"1046_CR16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00280-006-0394-3","volume":"60","author":"C Piard","year":"2007","unstructured":"Piard C, Bressolle F, Fakhoury M, Zhang D, Yacouben K, Rieutord A, Jacqz-Aigrain E (2007) A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 60(4):609\u2013620","journal-title":"Cancer Chemother Pharmacol"},{"issue":"13","key":"1046_CR17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2165\/00003088-200241130-00006","volume":"41","author":"A Rousseau","year":"2002","unstructured":"Rousseau A, Sabot C, Delepine N, Delepine G, Debord J, Lachatre G, Marquet P (2002) Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma. Clin Pharmacokinet 41(13):1095\u20131104","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"1046_CR18","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","volume":"111","author":"A Moricke","year":"2008","unstructured":"Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M, Loning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 111(9):4477\u20134489","journal-title":"Blood"},{"issue":"9","key":"1046_CR19","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D et al (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84(9):3122\u20133133","journal-title":"Blood"},{"key":"1046_CR20","unstructured":"ALL IC-BFM 2002\u2013Trial Steering Committee (2002) A randomized trial of the I-BFM-SG for the management of childhood non-B acute lymphoblastic leukemia final version of therapy protocol from May 3, 2002. ALL IC-BFM 2002\u2013Trial Steering Committee"},{"issue":"4","key":"1046_CR21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2008-1046608","volume":"206","author":"A Reiter","year":"1994","unstructured":"Reiter A, Tiemann M, Ludwig WD, Wacker HH, Yakisan E, Schrappe M, Henzler D, Sykora KW, Brandt A, Odenwald E et al (1994) NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin\u2019s lymphomas in children and adolescents. Part 1: classification and allocation to strategic therapy groups. BIF study group. Klin P\u00e4diatr 206(4):222\u2013233","journal-title":"Klin P\u00e4diatr"},{"issue":"1","key":"1046_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer\u2014treatment. Cancer 47(1):207\u2013214","journal-title":"Cancer"},{"issue":"3","key":"1046_CR23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215\u20131215","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1046_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.10195","volume":"108","author":"GM Shaw","year":"2002","unstructured":"Shaw GM, Lammer EJ, Zhu HP, Baker MW, Neri E, Finnell RH (2002) Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108(1):1\u20136","journal-title":"Am J Med Genet"},{"issue":"1","key":"1046_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(02)00204-6","volume":"166","author":"PF Jacques","year":"2003","unstructured":"Jacques PF, Bostom AG, Selhub J, Rich S, Ellison RC, Eckfeldt JH, Gravel RA, Rozen R (2003) Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 166(1):49\u201355","journal-title":"Atherosclerosis"},{"issue":"10","key":"1046_CR26","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood.V97.10.3205","volume":"97","author":"K Matsuo","year":"2001","unstructured":"Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, Kondoh E, Maeda S, Asakura S, Kaba S, Nakamura S, Seto M, Morishima Y, Tajima K (2001) Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97(10):3205\u20133209","journal-title":"Blood"},{"issue":"6","key":"1046_CR27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1054\/bjoc.2001.2007","volume":"85","author":"B Iacopetta","year":"2001","unstructured":"Iacopetta B, Grieu F, Joseph D, Elsaleh H (2001) A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer 85(6):827\u2013830","journal-title":"Br J Cancer"},{"issue":"1","key":"1046_CR28","first-page":"35","volume":"58","author":"M Kurzawski","year":"2006","unstructured":"Kurzawski M, Pawlik A, Gornik W, Drodzik M (2006) Frequency of common MDR1 gene variants in a Polish population. Pharmacol Rep 58(1):35\u201340","journal-title":"Pharmacol Rep"},{"issue":"11","key":"1046_CR29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00228-008-0521-7","volume":"64","author":"PB Grabar","year":"2008","unstructured":"Grabar PB, Logar D, Lestan B, Dolzan V (2008) Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Eur J Clin Pharmacol 64(11):1057\u20131068","journal-title":"Eur J Clin Pharmacol"},{"key":"1046_CR30","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO (2009) Prediction corrected visual predictive checks. Paper presented at the American Conference on Pharmacometrics (ACoP), Mashantucket, CT, USA. Available at: http:\/\/2009.go-acop.org\/acop2009\/posters . Accessed 24 Feb 2011"},{"issue":"4","key":"1046_CR31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/10428190601187711","volume":"48","author":"P Bohanec Grabar","year":"2007","unstructured":"Bohanec Grabar P, Jazbec J, Dolzan V (2007) Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 48(4):786\u2013792","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1046_CR32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354(2):166\u2013178","journal-title":"N Engl J Med"},{"key":"1046_CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-60327-088-5_17","volume-title":"Cancer drug discovery and development: genomics and pharmacogenomics in anticancer drug development and clinical response","author":"L Cunningham","year":"2008","unstructured":"Cunningham L, Aplenc R (2008) Role of the folate-pathway and the thymidylate synthase genes in pediatric acute lymphoblastic leukemia treatment response. In: Innocenti F (ed) Cancer drug discovery and development: genomics and pharmacogenomics in anticancer drug development and clinical response. Humana Press, Totowa, pp 299\u2013309"},{"issue":"5","key":"1046_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.2009.07765.x","volume":"146","author":"K Schmiegelow","year":"2009","unstructured":"Schmiegelow K (2009) Advances in individual prediction of methotrexate toxicity: a review. Br J Haematol 146(5):489\u2013503","journal-title":"Br J Haematol"},{"issue":"6","key":"1046_CR35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/138920009789375414","volume":"10","author":"G Gervasini","year":"2009","unstructured":"Gervasini G (2009) Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising. Curr Drug Metab 10(6):547\u2013566","journal-title":"Curr Drug Metab"},{"issue":"4","key":"1046_CR36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/fon.09.26","volume":"5","author":"YI Kim","year":"2009","unstructured":"Kim YI (2009) Role of the MTHFR polymorphisms in cancer risk modification and treatment. Future Oncol 5(4):523\u2013542","journal-title":"Future Oncol"},{"issue":"8","key":"1046_CR37","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1200\/JCO.1994.12.8.1667","volume":"12","author":"MV Relling","year":"1994","unstructured":"Relling MV, Fairclough D, Ayers D, Crom WR, Rodman JH, Pui CH, Evans WE (1994) Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 12(8):1667\u20131672","journal-title":"J Clin Oncol"},{"issue":"2","key":"1046_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.leu.2401673","volume":"14","author":"AM Wall","year":"2000","unstructured":"Wall AM, Gajjar A, Link A, Mahmoud H, Pui CH, Relling MV (2000) Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia. Leukemia 14(2):221\u2013225","journal-title":"Leukemia"},{"issue":"5","key":"1046_CR39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00280-006-0202-0","volume":"58","author":"DW Faltaos","year":"2006","unstructured":"Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan H, Leblond V, Lechat P (2006) Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy. Cancer Chemother Pharmacol 58(5):626\u2013633","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"1046_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2710.2002.00402.x","volume":"27","author":"S Monjanel-Mouterde","year":"2002","unstructured":"Monjanel-Mouterde S, Lejeune C, Ciccolini J, Merite N, Hadjaj D, Bonnier P, Piana P, Durand A (2002) Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer. J Clin Pharm Ther 27(3):189\u2013195","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"1046_CR41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0959-8049(02)00024-2","volume":"38","author":"MA Batey","year":"2002","unstructured":"Batey MA, Wright JG, Azzabi A, Newell DR, Lind MJ, Calvert AH, Boddy AV (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Eur J Cancer 38(8):1081\u20131089","journal-title":"Eur J Cancer"},{"issue":"10","key":"1046_CR42","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood.V100.10.3832","volume":"100","author":"C Laverdiere","year":"2002","unstructured":"Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M (2002) Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 100(10):3832\u20133834","journal-title":"Blood"},{"issue":"2","key":"1046_CR43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10038-006-0096-z","volume":"52","author":"H Imanishi","year":"2007","unstructured":"Imanishi H, Okamura N, Yagi M, Noro Y, Moriya Y, Nakamura T, Hayakawa A, Takeshima Y, Sakaeda T, Matsuo M, Okumura K (2007) Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J Hum Genet 52(2):166\u2013171","journal-title":"J Hum Genet"},{"issue":"9","key":"1046_CR44","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/leu.2008.66","volume":"22","author":"L Huang","year":"2008","unstructured":"Huang L, Tissing WJ, de Jonge R, van Zelst BD, Pieters R (2008) Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia. Leukemia 22(9):1798\u20131800","journal-title":"Leukemia"},{"issue":"6","key":"1046_CR45","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/10428190902893819","volume":"50","author":"M Kantar","year":"2009","unstructured":"Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, Topcuoglu N, Aksoylar S, Cinar M, Tetik A, Eroglu Z (2009) Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Leuk Lymphoma 50(6):912\u2013917","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1046_CR46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0609.2008.01128.x","volume":"81","author":"PB Kooten Niekerk van","year":"2008","unstructured":"van Kooten Niekerk PB, Schmiegelow K, Schroeder H (2008) Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate. Eur J Haematol 81(5):391\u2013398","journal-title":"Eur J Haematol"},{"issue":"16","key":"1046_CR47","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2003.07.056","volume":"21","author":"S Kishi","year":"2003","unstructured":"Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui CH, Relling MV (2003) Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21(16):3084\u20133091","journal-title":"J Clin Oncol"},{"issue":"5","key":"1046_CR48","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00277-005-0072-2","volume":"85","author":"K Seidemann","year":"2006","unstructured":"Seidemann K, Book M, Zimmermann M, Meyer U, Welte K, Stanulla M, Reiter A (2006) MTHFR 677 \u00a9\u2013\u2009>\u2009T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95. Ann Hematol 85(5):291\u2013300","journal-title":"Ann Hematol"},{"issue":"2","key":"1046_CR49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.mph.0000198269.61948.90","volume":"28","author":"N Shimasaki","year":"2006","unstructured":"Shimasaki N, Mori T, Samejima H, Sato R, Shimada H, Yahagi N, Torii C, Yoshihara H, Tanigawara Y, Takahashi T, Kosaki K (2006) Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol \/Oncol 28(2):64\u201368","journal-title":"J Pediatr Hematol \/Oncol"},{"issue":"5","key":"1046_CR50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPH.0b013e318165b25d","volume":"30","author":"N Shimasaki","year":"2008","unstructured":"Shimasaki N, Mori T, Torii C, Sato R, Shimada H, Tanigawara Y, Kosaki K, Takahashi T (2008) Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol\/Oncol 30(5):347\u2013352","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"4","key":"1046_CR51","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/10428191003611402","volume":"51","author":"B Faganel Kotnik","year":"2010","unstructured":"Faganel Kotnik B, Dolzan V, Grabnar I, Jazbec J (2010) Relationship of the reduced folate carrier gene polymorphism G80A to methotrexate plasma concentration, toxicity, and disease outcome in childhood acute lymphoblastic leukemia. Leuk Lymphoma 51(4):724\u2013726","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"1046_CR52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.tpj.6500332","volume":"5","author":"M Krajinovic","year":"2005","unstructured":"Krajinovic M, Costea I, Primeau M, Dulucq S, Moghrabi A (2005) Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis. Pharmacogenomics J 5(6):374\u2013380","journal-title":"Pharmacogenomics J"},{"issue":"35","key":"1046_CR53","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1200\/JCO.2008.20.4156","volume":"27","author":"LR Trevino","year":"2009","unstructured":"Trevino LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, Chan D, Sparreboom A, Giacomini KM, Pui CH, Evans WE, Relling MV (2009) Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol 27(35):5972\u20135978","journal-title":"J Clin Oncol"},{"issue":"5","key":"1046_CR54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2006.08.012","volume":"80","author":"T Rau","year":"2006","unstructured":"Rau T, Erney B, Gores R, Eschenhagen T, Beck J, Langer T (2006) High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations. Clin Pharmacol Ther 80(5):468\u2013476","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1046-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-011-1046-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-011-1046-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T03:47:24Z","timestamp":1712375244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-011-1046-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,21]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1007\/s00228-011-1046-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,21]]}}}